A Nikkei Asia investigation has put a Japan-based corporate trail at the center of suspected crypto-fraud activity tied to a Chinese fentanyl-precursor network. The case centers on Firsky KK, a company registered in Nagoya, and its connections to Hubei Amarvel Biotech, the Wuhan chemical supplier whose executives were convicted in the U.S. over fentanyl-precursor importation and money laundering offenses. The Japan route had already been under scrutiny because investigators traced a web of companies, websites, sales identities, and shipment claims through Firsky and Amarvel. The latest reporting shifts the focus from shipping cover alone to whether the same Japan-facing structure also helped support crypto-related fraud.